"Nov. 12, 2012 -- The requirement to fast before a cholesterol check can be a major inconvenience.
People who forget to fast may be told to reschedule their appointments. For those who remember, sitting in a doctor's waiting room with "...
Lipofen Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Lipofen (fenofibrate) is used to treat high cholesterol and high triglyceride levels. It helps reduce cholesterol and triglycerides (fatty acids) in the blood. High levels of these types of fat in the blood are associated with an increased risk of atherosclerosis (clogged arteries). Many people using this medication do not have serious side effects. It may infrequently cause gallstones and liver problems. Tell your doctor if severe stomach/abdominal pain, persistent nausea/vomiting, yellowing eyes/skin, or dark urine occurs.
The dose of Lipofen ranges from 50 mg to 150 mg taken once daily, with meals. Lipofen may interact with blood thinners, cyclosporine, or other cholesterol-lowering medicines. Tell your doctor all medications and supplements you use. Lipofen is not recommended for use during pregnancy. It is unknown if this medication passes into breast milk. Because of the possible risk to the infant, breastfeeding while using this drug is not recommended.
Our Lipofen (fenofibrate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Lipofen in Detail - Patient Information: Side Effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
In rare cases, fenofibrate can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, and dark colored urine.
Stop using fenofibrate and call your doctor at once if you have:
- severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate;
- easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;
- chest pain, sudden cough, wheezing, rapid breathing, coughing up blood; or
- pain, swelling, warmth, or redness in one or both legs.
Common side effects may include:
- mild stomach pain;
- back pain;
- headache; or
- runny or stuffy nose.
Read the entire detailed patient monograph for Lipofen (Fenofibrate)
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Lipofen FDA Prescribing Information: Side Effects
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rate observed in clinical practice.
Adverse reactions reported by 2% or more of patients treated with fenofibrate (and greater than placebo) during the double-blind, placebo-controlled trials, regardless of causality, are listed in Table 1 below. Adverse events led to discontinuation of treatment in 5.0% of patients treated with fenofibrate and in 3.0% treated with placebo. Increases in liver function tests were the most frequent events, causing discontinuation of fenofibrate treatment in 1.6% of patients in double-blind trials.
Table 1: Adverse Reactions
Reported by 2% or More of Patients Treated with Fenofibrate and Greater than
Placebo During the Double-Blind, Placebo-Controlled Trials
|BODY SYSTEM Adverse Event||Fenofibrate*
|BODY AS A WHOLE|
|Abnormal Liver Function Tests||7.5%**||1.4%|
|METABOLIC AND NUTRITIONAL DISORDERS|
|Creatine Phosphokinase Increased||3.0%||1.4%|
|* Dosage equivalent to 150 mg LIPOFEN
** Significantly different from placebo
The following adverse reactions have been identified during postapproval use of fenofibrate: myalgia, rhabdomyolysis, pancreatitis, acute renal failure, muscle spasm, hepatitis, cirrhosis, anemia, arthralgia, decreases in hemoglobin, decreases in hematocrit, white blood cell decreases, asthenia, and severely depressed HDL cholesterol levels. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Read the entire FDA prescribing information for Lipofen (Fenofibrate)
Additional Lipofen Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Tips to keep it under control.